Consumer Staples [ 10/12 ] | Personal Care Products [ 56/73 ]
NASDAQ | Common Stock
United-Guardian, Inc. develops, manufactures, sells, and markets specialty cosmetic ingredients, pharmaceutical products, medical lubricants, and sexual wellness ingredients in the United States and internationally.
The company offers cosmetic ingredients, including LUBRAJEL, a line of multifunctional hydrogel formulations for personal care and medical products; B-122, a powdered lubricant used in the manufacture of certain cosmetics, such as pressed powders, eyeliners, and rouges, as well as some industrial products; ORCHID COMPLEX, an oil-based extract of orchids; and LUBRASIL II SB, a special formulation of Lubrajel in which silicone oil is incorporated into a Lubrajel base.
It also provides medical lubricant products for catheter lubrication, medical devices, condom lubrication, and oral care under the Lubrajel brand, including Lubrajel MG, Lubrajel MGL, Lubrajel RRCG, Lubrajel RR, Lubrajel RC, Lubrajel RA, Lubrajel Fluid, Lubrajel LC, Lubrajel BA, and Lubrajel FACO.
In addition, the company offers pharmaceutical products comprising RENACIDIN, a prescription to prevent and to dissolve calcifications in urethral catheters; and CLORPACTIN WCS-90, a chlorine-based drug, which is a topical antimicrobial and is also used in urology.
Further, it provides sexual wellness ingredient products, which are hydrogel formulations designed to offer sensory enhancement, lubrication, and moisturization, such as Natrajel NT, Natrajel MA, Natrajel ON, and Natrajel TE product lines.
United-Guardian, Inc. was founded in 1942 and is based in Hauppauge, New York.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 8, 25 | 0.12 Decreased by -39.37% | - |
| Mar 20, 25 | 0.11 Decreased by -31.71% | - |
| Nov 4, 24 | 0.19 Increased by +34.57% | - |
| Aug 9, 24 | 0.21 Increased by +107.27% | - |
| May 10, 24 | 0.20 Increased by +22.36% | - |
| Mar 22, 24 | 0.16 Increased by +7.00% | - |
| Nov 6, 23 | 0.14 Increased by +86.17% | - |
| Aug 11, 23 | 0.10 Decreased by -28.29% | - |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 25 | 2.48 M Decreased by -23.77% | 560.89 K Decreased by -39.39% | Increased by +22.61% Decreased by -20.49% |
| Dec 31, 24 | 2.48 M Decreased by -5.00% | 503.72 K Decreased by -31.69% | Increased by +20.34% Decreased by -28.10% |
| Sep 30, 24 | 3.06 M Increased by +0.08% | 865.48 K Increased by +38.09% | Increased by +28.28% Increased by +37.97% |
| Jun 30, 24 | 3.39 M Increased by +27.92% | 956.23 K Increased by +107.38% | Increased by +28.21% Increased by +62.12% |
| Mar 31, 24 | 3.25 M Increased by +26.64% | 925.44 K Increased by +22.40% | Increased by +28.43% Decreased by -3.34% |
| Dec 31, 23 | 2.61 M Decreased by -5.64% | 737.44 K Increased by +8.57% | Increased by +28.29% Increased by +15.07% |
| Sep 30, 23 | 3.06 M Increased by +26.50% | 626.76 K Increased by +81.40% | Increased by +20.50% Increased by +43.40% |
| Jun 30, 23 | 2.65 M Decreased by -26.91% | 461.09 K Decreased by -27.19% | Increased by +17.40% Decreased by -0.39% |